WHO Flu Framework Looks At Virus Genetic Information Sharing, Private Sector Contribution 28/03/2017 by Catherine Saez, Intellectual Property Watch 2 Comments How to deal with genetic information rather than physical samples of pandemic influenza virus continues to be discussed at the World Health Organization. For the moment, only physical samples are part of a framework of access and benefit sharing set up and run by the WHO. This week, the framework advisory group is meeting and according to sources, suggested steps to establish guidance on how to address virus genetic information will be shared by the WHO during the meeting.
Civil Society From 17 European Countries File Patent Opposition On Key Hepatitis C Drug 27/03/2017 by Intellectual Property Watch 2 Comments Public health group Médecins Sans Frontières (MSF) announced today that it has joined civil society organisations from 17 countries in Europe in filing a patent challenge at the European Patent Office to Gilead’s patent on sofosbuvir, an important treatment for hepatitis C.
UK Professor Charts Path To Reconciling IP Rights, Farmers’ Rights 27/03/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The role of farmers in agricultural innovation can be perceived in different ways. Proponents of intellectual property rights view farmers mainly as recipients of innovation, while others view farmers as main drivers of innovation. Considering those seemingly contradictory points of views, some measures could help reconcile IP rights and farmers’ rights, a UK professor in international governance has said.
Situation With IP Rights In Russia Continues To Deteriorate 27/03/2017 by Eugene Gerden for Intellectual Property Watch Leave a Comment The situation with IP rights in Russia is steadily deteriorating, which is mainly due to the recently imposed restrictions for foreign biopharmaceutical companies to participate in public procurement procedures in Russia, the encouragement of parallel imports, as well as the increased consumption of pirated software, according to recent statements of the Russian Ministry of Industry and Trade and local analysts in the field of IP protection.
Medicines Patent Pool Sublicenses New Antibiotic Candidate To TB Alliance For Development 24/03/2017 by Intellectual Property Watch 2 Comments TB Alliance and the Medicines Patent Pool announced today a licensing agreement for the development of sutezolid, a new antibiotic drug candidate which may be used to treat tuberculosis.
Will Brexit Block The European Unitary Patent? 23/03/2017 by Intellectual Property Watch 1 Comment European Patent Office President Benoît Battistelli today in Brussels expressed confidence that the first European Union unitary patent could be granted by the end of this year despite continued delays in the ratification process.But doubts remain.
Mining Is The New Reading 23/03/2017 by Monika Ermert for Intellectual Property Watch 1 Comment Representatives of the research and academic community applauded amendments by the rapporteur to the draft new European Union Copyright Directive in yet another hearing on the megaproject yesterday in Brussels. Especially welcomed was the rapporteur’s proposal to extend the scope of an exemption for text and data mining. Representatives of publishers, on the other hand, said there is no evidence of the need for additional mandatory exemptions.
Country Names As IP, Geographical Indications, Industrial Designs At WIPO Next Week 23/03/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment What can you do if you are a country and a private company has registered your name as a trademark, preventing even your own companies from using your name? The issue is expected to be discussed at next week’s World Intellectual Property Organization’s committee on trademarks. The meeting also includes a special session illustrating practices of national and regional protection of geographical indications. However, the question remains whether or not delegates will discuss a draft treaty text on industrial designs, after that conversation was pushed back in the fall.
EU Parliament: No Commercial Availability Or Compensation In Marrakesh Implementation 23/03/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The European Parliament announced today that its Legal Affairs Committee approved new draft legislation to bring European Union law into line with an international treaty providing copyright exceptions for special format books for visually impaired people. Limitations to the scope of the treaty, such as commercial availability or compensation, were disregarded by Parliament members.
What To Watch Out For In The EU-Mercosur FTA Negotiations: Consequences For Access To Medicines 22/03/2017 by Intellectual Property Watch 6 Comments As negotiations take place this week, an evaluation of the impact of one of the TRIPS-plus measures of the Mercosur/EU FTA on the prices of medicines in Brazil has been released. Based on the draft of the agreement, by their calculations, an additional USD 444 million would be necessary to be spent by the public health system for the purchase of six medicines alone, write Marcela Fogaça Vieira and Gabriela Costa Chaves.